Rapamycin-Induced Cytotoxic Signal Transduction Pathway

被引:9
作者
Choi, S. J. N. [1 ]
You, H. S. [1 ]
Chung, S. Y. [1 ]
机构
[1] Chonnam Natl Univ, Div Transplantat Surg, Dept Surg, Sch Med, Kwangju 501190, South Korea
关键词
D O I
10.1016/j.transproceed.2008.08.029
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We examined the effects of rapamycin oil activation, proliferation, and expression of cytotoxic effector molecules in Molt-4 human T lymphocytes. We investigated the effects of rapamycin on cell viability, caspase family protein activities. Western blots of Bcl-2, Bak, p53 p21, p27 Rb, CDK2, and cyclin B1, as well as measurement of reactive oxygen species (ROS) generation and mitochondrial membrane potential transition. Cells were Cultured in the presence or absence of rapamycin. Flow cytometric analysis was performed using propidium iodide stain. Viability of Molt-4 cells was decreased by the addition of rapamycin in dose- and time-dependent manners. Rapamycin induced no nuclear fragmentation in Molt-4 cells. Generation of H2O2 in rapamycin-treated Molt-4 cells increased in a time-dependent manner. There were no changes among catalytic activities of caspase proteases. And there was no evidence of expression of Bcl-2, p53, p21, p27, or Rb proteins. G2/M phase cell cycle arrest was identified by flow cytometry. We noted decreased expressions of CDK2 and cyclin B1. We also noted increased Bak protein expression and change in mitochondrial membrane potential transition. In conclusion, rapamycin-induced cytotoxicity was characterized by generation of ROS, which modulated Bak protein expression and mitochondrial dysfunction. G2/M phase cell cycle arrest was achieved by decreased expressions of CDK2 and cyclin B1.
引用
收藏
页码:2737 / 2739
页数:3
相关论文
共 9 条
[1]   Sirolimus monotherapy as maintenance immunosuppression: Single-center experience in 50 kidney transplant patients [J].
Arellano, E. M. ;
Campistol, J. M. ;
Oppenheimer, F. ;
Rovira, J. ;
Diekmann, F. .
TRANSPLANTATION PROCEEDINGS, 2007, 39 (07) :2131-2134
[2]   Rapamycin inhibits proliferation and differentiation of human endothelial progenitor cells in vitro [J].
Butzal, M ;
Loges, S ;
Schweizer, M ;
Fischer, U ;
Gehling, UM ;
Hossfeld, DK ;
Fiedler, W .
EXPERIMENTAL CELL RESEARCH, 2004, 300 (01) :65-71
[3]   Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine a because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis [J].
Koenen, HJPM ;
Michielsen, ECHJ ;
Verstappen, J ;
Fasse, E ;
Joosten, I .
TRANSPLANTATION, 2003, 75 (09) :1581-1590
[4]   Rapamycin impairs antigen uptake of human dendritic cells [J].
Monti, P ;
Mercalli, A ;
Leone, BE ;
Valerio, DC ;
Allavena, P ;
Piemonti, L .
TRANSPLANTATION, 2003, 75 (01) :137-145
[5]   mTOR inhibitors:: Do they help preserve renal function? [J].
Moro, J. ;
Almenar, L. ;
Martinez-Dolz, L. ;
Agueero, J. ;
Rueda, J. ;
Arnau, M. A. ;
Lzquierdo, M. ;
Cano, O. ;
Sanchez-Lazaro, I. ;
Salvador, A. .
TRANSPLANTATION PROCEEDINGS, 2007, 39 (07) :2135-2137
[6]   Rapamycin in transplantation: A review of the evidence [J].
Saunders, RN ;
Metcalfe, MS ;
Nicholson, ML .
KIDNEY INTERNATIONAL, 2001, 59 (01) :3-16
[7]   Conversion from calcineurin inhibitors to Sirolimus in kidney transplant patients reduces the urinary transforming growth factor-β1 concentration [J].
Saurina, A. ;
Campistol, J. M. ;
Lario, S. ;
Oppenheimer, F. ;
Diekmann, F. .
TRANSPLANTATION PROCEEDINGS, 2007, 39 (07) :2138-2141
[8]   TOR, a central controller of cell growth [J].
Schmelzle, T ;
Hall, MN .
CELL, 2000, 103 (02) :253-262
[9]   Apoptosis and caspase-3 in long-term renal ischemia/reperfusion injury in rats and divergent effects of immunosuppressants [J].
Yang, Bin ;
Jain, Sunjay ;
Ashra, Shairbanu Y. ;
Furness, Peter N. ;
Nicholson, Michael L. .
TRANSPLANTATION, 2006, 81 (10) :1442-1450